25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Hangzhou Alltest Biotech Co. Ltd. A
Buy, Hold or Sell?

Let's analyze Hangzhou Alltest Biotech Co. Ltd. A together

I guess you are interested in Hangzhou Alltest Biotech Co. Ltd. A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hangzhou Alltest Biotech Co. Ltd. A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hangzhou Alltest Biotech Co. Ltd. A

I send you an email if I find something interesting about Hangzhou Alltest Biotech Co. Ltd. A.

1. Quick Overview

1.1. Quick analysis of Hangzhou Alltest Biotech Co. Ltd. A (30 sec.)










1.2. What can you expect buying and holding a share of Hangzhou Alltest Biotech Co. Ltd. A? (30 sec.)

How much money do you get?

How much money do you get?
¥3.68
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
¥48.33
Expected worth in 1 year
¥32.53
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥10.88
Return On Investment
15.6%

For what price can you sell your share?

Current Price per Share
¥69.89
Expected price per share
¥61.26 - ¥78.27
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hangzhou Alltest Biotech Co. Ltd. A (5 min.)




Live pricePrice per Share (EOD)
¥69.89
Intrinsic Value Per Share
¥-128.17 - ¥-157.76
Total Value Per Share
¥-79.85 - ¥-109.43

2.2. Growth of Hangzhou Alltest Biotech Co. Ltd. A (5 min.)




Is Hangzhou Alltest Biotech Co. Ltd. A growing?

Current yearPrevious yearGrowGrow %
How rich?$528.3m$575.1m-$46.7m-8.8%

How much money is Hangzhou Alltest Biotech Co. Ltd. A making?

Current yearPrevious yearGrowGrow %
Making money$24.9m$163.4m-$138.4m-556.2%
Net Profit Margin23.9%35.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Hangzhou Alltest Biotech Co. Ltd. A (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hangzhou Alltest Biotech Co. Ltd. A?

Welcome investor! Hangzhou Alltest Biotech Co. Ltd. A's management wants to use your money to grow the business. In return you get a share of Hangzhou Alltest Biotech Co. Ltd. A.

First you should know what it really means to hold a share of Hangzhou Alltest Biotech Co. Ltd. A. And how you can make/lose money.

Speculation

The Price per Share of Hangzhou Alltest Biotech Co. Ltd. A is ¥69.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hangzhou Alltest Biotech Co. Ltd. A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hangzhou Alltest Biotech Co. Ltd. A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥48.33. Based on the TTM, the Book Value Change Per Share is ¥-3.95 per quarter. Based on the YOY, the Book Value Change Per Share is ¥11.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥6.67 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hangzhou Alltest Biotech Co. Ltd. A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.310.4%0.310.4%2.052.9%1.001.4%1.001.4%
Usd Book Value Change Per Share-0.54-0.8%-0.54-0.8%1.552.2%1.331.9%1.331.9%
Usd Dividend Per Share0.921.3%0.921.3%0.370.5%0.300.4%0.300.4%
Usd Total Gains Per Share0.380.5%0.380.5%1.922.8%1.632.3%1.632.3%
Usd Price Per Share9.46-9.46-14.40-8.16-8.16-
Price to Earnings Ratio30.12-30.12-7.03-9.99-9.99-
Price-to-Total Gains Ratio25.22-25.22-7.49-12.26-12.26-
Price to Book Ratio1.42-1.42-2.00-1.28-1.28-
Price-to-Total Gains Ratio25.22-25.22-7.49-12.26-12.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.637831
Number of shares103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.920.30
Usd Book Value Change Per Share-0.541.33
Usd Total Gains Per Share0.381.63
Gains per Quarter (103 shares)38.63167.75
Gains per Year (103 shares)154.52671.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1379-224145122549661
2758-44930024410981332
31137-67345536616472003
41516-89761048721972674
51894-112276560927463345
62273-134692073132954016
72652-1571107585338444687
83031-1795123097543935358
93410-20191385109749426029
103789-22441540121854926700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%3.00.02.060.0%3.00.02.060.0%3.00.02.060.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hangzhou Alltest Biotech Co. Ltd. A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.949-3.9490%11.244-135%9.666-141%9.666-141%
Book Value Per Share--48.32948.3290%52.278-8%31.521+53%31.521+53%
Current Ratio--11.53111.5310%8.202+41%7.326+57%7.326+57%
Debt To Asset Ratio--0.0690.0690%0.112-38%0.128-46%0.128-46%
Debt To Equity Ratio--0.0740.0740%0.126-41%0.149-50%0.149-50%
Dividend Per Share--6.6696.6690%2.703+147%2.145+211%2.145+211%
Enterprise Value--5154169759.9305154169759.9300%7804633823.217-34%7345870852.403-30%7345870852.403-30%
Eps--2.2782.2780%14.853-85%7.257-69%7.257-69%
Ev To Ebitda Ratio--infinfnan%5.415+inf%infnan%infnan%
Ev To Sales Ratio--6.8296.8290%2.303+197%4.660+47%4.660+47%
Free Cash Flow Per Share---6.417-6.4170%13.668-147%5.085-226%5.085-226%
Free Cash Flow To Equity Per Share---6.417-6.4170%13.668-147%5.085-226%5.085-226%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---157.755--------
Intrinsic Value_10Y_min---128.174--------
Intrinsic Value_1Y_max--1.059--------
Intrinsic Value_1Y_min--1.029--------
Intrinsic Value_3Y_max---9.673--------
Intrinsic Value_3Y_min---8.905--------
Intrinsic Value_5Y_max---35.902--------
Intrinsic Value_5Y_min---31.913--------
Market Cap5540941821.440+2%5438669465.6005438669465.6000%8328829211.787-35%4716202983.708+15%4716202983.708+15%
Net Profit Margin--0.2390.2390%0.350-32%0.384-38%0.384-38%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.3441.3440%0.919+46%0.945+42%0.945+42%
Pb Ratio1.446+2%1.4191.4190%1.997-29%1.283+11%1.283+11%
Pe Ratio30.685+2%30.11830.1180%7.029+328%9.993+201%9.993+201%
Price Per Share69.890+2%68.60068.6000%104.400-34%59.202+16%59.202+16%
Price To Free Cash Flow Ratio-10.892-2%-10.691-10.6910%7.638-240%1.894-665%1.894-665%
Price To Total Gains Ratio25.697+2%25.22325.2230%7.486+237%12.264+106%12.264+106%
Quick Ratio--5.7355.7350%3.860+49%3.422+68%3.422+68%
Return On Assets--0.0440.0440%0.252-83%0.262-83%0.262-83%
Return On Equity--0.0470.0470%0.284-83%0.306-85%0.306-85%
Total Gains Per Share--2.7202.7200%13.946-80%11.810-77%11.810-77%
Usd Book Value--528371857.467528371857.4670%575129471.945-8%345891430.029+53%345891430.029+53%
Usd Book Value Change Per Share---0.545-0.5450%1.550-135%1.333-141%1.333-141%
Usd Book Value Per Share--6.6656.6650%7.209-8%4.347+53%4.347+53%
Usd Dividend Per Share--0.9200.9200%0.373+147%0.296+211%0.296+211%
Usd Enterprise Value--710760009.894710760009.8940%1076259004.222-34%1012995590.546-30%1012995590.546-30%
Usd Eps--0.3140.3140%2.048-85%1.001-69%1.001-69%
Usd Free Cash Flow---70153663.302-70153663.3020%150372493.346-147%55919027.183-225%55919027.183-225%
Usd Free Cash Flow Per Share---0.885-0.8850%1.885-147%0.701-226%0.701-226%
Usd Free Cash Flow To Equity Per Share---0.885-0.8850%1.885-147%0.701-226%0.701-226%
Usd Market Cap764095877.177+2%749992519.306749992519.3060%1148545548.305-35%650364391.453+15%650364391.453+15%
Usd Price Per Share9.638+2%9.4609.4600%14.397-34%8.164+16%8.164+16%
Usd Profit--24901456.63024901456.6300%163401063.882-85%79674157.311-69%79674157.311-69%
Usd Revenue--104072700.974104072700.9740%467283546.563-78%203914998.000-49%203914998.000-49%
Usd Total Gains Per Share--0.3750.3750%1.923-80%1.629-77%1.629-77%
 EOD+5 -3MRQTTM+0 -0YOY+12 -265Y+15 -2210Y+15 -22

3.3 Fundamental Score

Let's check the fundamental score of Hangzhou Alltest Biotech Co. Ltd. A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.685
Price to Book Ratio (EOD)Between0-11.446
Net Profit Margin (MRQ)Greater than00.239
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.735
Current Ratio (MRQ)Greater than111.531
Debt to Asset Ratio (MRQ)Less than10.069
Debt to Equity Ratio (MRQ)Less than10.074
Return on Equity (MRQ)Greater than0.150.047
Return on Assets (MRQ)Greater than0.050.044
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Hangzhou Alltest Biotech Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.084
Ma 20Greater thanMa 5065.676
Ma 50Greater thanMa 10066.779
Ma 100Greater thanMa 20064.809
OpenGreater thanClose68.540
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Hangzhou Alltest Biotech Co. Ltd. A

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Fundamental data was last updated by Penke on 2025-01-12 14:47:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hangzhou Alltest Biotech Co. Ltd. A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 23.9% means that ¥0.24 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 23.9%. The company is making a huge profit. +2
  • The TTM is 23.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.9%TTM23.9%0.0%
TTM23.9%YOY35.0%-11.0%
TTM23.9%5Y38.4%-14.5%
5Y38.4%10Y38.4%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ23.9%5.5%+18.4%
TTM23.9%4.7%+19.2%
YOY35.0%7.3%+27.7%
5Y38.4%7.1%+31.3%
10Y38.4%7.4%+31.0%
4.3.1.2. Return on Assets

Shows how efficient Hangzhou Alltest Biotech Co. Ltd. A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • 4.4% Return on Assets means that Hangzhou Alltest Biotech Co. Ltd. A generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY25.2%-20.9%
TTM4.4%5Y26.2%-21.8%
5Y26.2%10Y26.2%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%0.9%+3.5%
TTM4.4%0.8%+3.6%
YOY25.2%1.5%+23.7%
5Y26.2%1.8%+24.4%
10Y26.2%1.7%+24.5%
4.3.1.3. Return on Equity

Shows how efficient Hangzhou Alltest Biotech Co. Ltd. A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • 4.7% Return on Equity means Hangzhou Alltest Biotech Co. Ltd. A generated ¥0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 4.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.7%TTM4.7%0.0%
TTM4.7%YOY28.4%-23.7%
TTM4.7%5Y30.6%-25.9%
5Y30.6%10Y30.6%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7%2.1%+2.6%
TTM4.7%1.7%+3.0%
YOY28.4%2.7%+25.7%
5Y30.6%3.1%+27.5%
10Y30.6%3.3%+27.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hangzhou Alltest Biotech Co. Ltd. A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hangzhou Alltest Biotech Co. Ltd. A is operating .

  • Measures how much profit Hangzhou Alltest Biotech Co. Ltd. A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.3%-8.3%
TTM-7.3%-7.3%
YOY-9.1%-9.1%
5Y-9.6%-9.6%
10Y-10.3%-10.3%
4.3.2.2. Operating Ratio

Measures how efficient Hangzhou Alltest Biotech Co. Ltd. A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are ¥1.34 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 1.344. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.344. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.344TTM1.3440.000
TTM1.344YOY0.919+0.425
TTM1.3445Y0.945+0.399
5Y0.94510Y0.9450.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3441.056+0.288
TTM1.3441.073+0.271
YOY0.9191.015-0.096
5Y0.9451.018-0.073
10Y0.9451.008-0.063
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hangzhou Alltest Biotech Co. Ltd. A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hangzhou Alltest Biotech Co. Ltd. A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 11.53 means the company has ¥11.53 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 11.531. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.531. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.531TTM11.5310.000
TTM11.531YOY8.202+3.329
TTM11.5315Y7.326+4.205
5Y7.32610Y7.3260.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5312.044+9.487
TTM11.5312.135+9.396
YOY8.2022.471+5.731
5Y7.3262.652+4.674
10Y7.3262.618+4.708
4.4.3.2. Quick Ratio

Measures if Hangzhou Alltest Biotech Co. Ltd. A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 5.73 means the company can pay off ¥5.73 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 5.735. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.735. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.735TTM5.7350.000
TTM5.735YOY3.860+1.875
TTM5.7355Y3.422+2.312
5Y3.42210Y3.4220.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7350.946+4.789
TTM5.7351.052+4.683
YOY3.8601.229+2.631
5Y3.4221.476+1.946
10Y3.4221.606+1.816
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hangzhou Alltest Biotech Co. Ltd. A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hangzhou Alltest Biotech Co. Ltd. A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.07 means that Hangzhou Alltest Biotech Co. Ltd. A assets are financed with 6.9% credit (debt) and the remaining percentage (100% - 6.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 0.069. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.069. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.069TTM0.0690.000
TTM0.069YOY0.112-0.043
TTM0.0695Y0.128-0.059
5Y0.12810Y0.1280.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0690.389-0.320
TTM0.0690.358-0.289
YOY0.1120.345-0.233
5Y0.1280.365-0.237
10Y0.1280.376-0.248
4.5.4.2. Debt to Equity Ratio

Measures if Hangzhou Alltest Biotech Co. Ltd. A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 7.4% means that company has ¥0.07 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The MRQ is 0.074. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.074. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.0740.000
TTM0.074YOY0.126-0.051
TTM0.0745Y0.149-0.075
5Y0.14910Y0.1490.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.564-0.490
TTM0.0740.535-0.461
YOY0.1260.520-0.394
5Y0.1490.587-0.438
10Y0.1490.673-0.524
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hangzhou Alltest Biotech Co. Ltd. A generates.

  • Above 15 is considered overpriced but always compare Hangzhou Alltest Biotech Co. Ltd. A to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 30.12 means the investor is paying ¥30.12 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The EOD is 30.685. Based on the earnings, the company is overpriced. -1
  • The MRQ is 30.118. Based on the earnings, the company is overpriced. -1
  • The TTM is 30.118. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.685MRQ30.118+0.566
MRQ30.118TTM30.1180.000
TTM30.118YOY7.029+23.089
TTM30.1185Y9.993+20.126
5Y9.99310Y9.9930.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD30.68516.664+14.021
MRQ30.11816.871+13.247
TTM30.11816.524+13.594
YOY7.02919.116-12.087
5Y9.99321.344-11.351
10Y9.99323.496-13.503
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The EOD is -10.892. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.691. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.691. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.892MRQ-10.691-0.201
MRQ-10.691TTM-10.6910.000
TTM-10.691YOY7.638-18.329
TTM-10.6915Y1.894-12.584
5Y1.89410Y1.8940.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-10.89210.195-21.087
MRQ-10.69111.254-21.945
TTM-10.6917.872-18.563
YOY7.638-0.467+8.105
5Y1.8945.142-3.248
10Y1.894-1.777+3.671
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hangzhou Alltest Biotech Co. Ltd. A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.42 means the investor is paying ¥1.42 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hangzhou Alltest Biotech Co. Ltd. A:

  • The EOD is 1.446. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.419. Based on the equity, the company is underpriced. +1
  • The TTM is 1.419. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.446MRQ1.419+0.027
MRQ1.419TTM1.4190.000
TTM1.419YOY1.997-0.578
TTM1.4195Y1.283+0.137
5Y1.28310Y1.2830.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.4462.726-1.280
MRQ1.4192.626-1.207
TTM1.4192.697-1.278
YOY1.9972.716-0.719
5Y1.2833.598-2.315
10Y1.2834.358-3.075
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,116,058
Total Liabilities284,500
Total Stockholder Equity3,827,249
 As reported
Total Liabilities 284,500
Total Stockholder Equity+ 3,827,249
Total Assets = 4,116,058

Assets

Total Assets4,116,058
Total Current Assets3,161,448
Long-term Assets954,610
Total Current Assets
Cash And Cash Equivalents 1,317,553
Short-term Investments 1,471,354
Net Receivables 100,870
Inventory 188,595
Other Current Assets 61,839
Total Current Assets  (as reported)3,161,448
Total Current Assets  (calculated)3,140,210
+/- 21,238
Long-term Assets
Property Plant Equipment 759,803
Intangible Assets 110,434
Long-term Assets Other 1,820
Long-term Assets  (as reported)954,610
Long-term Assets  (calculated)872,058
+/- 82,552

Liabilities & Shareholders' Equity

Total Current Liabilities274,163
Long-term Liabilities10,337
Total Stockholder Equity3,827,249
Total Current Liabilities
Short Long Term Debt 16,257
Accounts payable 77,609
Other Current Liabilities 160
Total Current Liabilities  (as reported)274,163
Total Current Liabilities  (calculated)94,026
+/- 180,137
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,657
Long-term Liabilities  (as reported)10,337
Long-term Liabilities  (calculated)7,657
+/- 2,680
Total Stockholder Equity
Retained Earnings 1,841,175
Total Stockholder Equity (as reported)3,827,249
Total Stockholder Equity (calculated)1,841,175
+/- 1,986,074
Other
Capital Stock79,281
Common Stock Shares Outstanding 79,281
Net Invested Capital 3,843,506
Net Working Capital 2,887,285
Property Plant and Equipment Gross 879,864



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
332,505
1,155,233
4,008,344
4,694,822
4,116,058
4,116,0584,694,8224,008,3441,155,233332,505
   > Total Current Assets 
239,478
1,024,119
3,668,178
4,189,174
3,161,448
3,161,4484,189,1743,668,1781,024,119239,478
       Cash And Cash Equivalents 
63,254
285,639
2,179,315
1,981,843
1,317,553
1,317,5531,981,8432,179,315285,63963,254
       Short-term Investments 
62,000
415,000
780,203
1,832,879
1,471,354
1,471,3541,832,879780,203415,00062,000
       Net Receivables 
53,216
163,435
208,199
138,663
100,870
100,870138,663208,199163,43553,216
       Inventory 
54,500
123,726
383,841
193,660
188,595
188,595193,660383,841123,72654,500
       Other Current Assets 
4,306
16,768
18,404
9,711
61,839
61,8399,71118,40416,7684,306
   > Long-term Assets 
93,027
131,114
340,166
505,648
954,610
954,610505,648340,166131,11493,027
       Property Plant Equipment 
0
71,995
223,622
317,145
759,803
759,803317,145223,62271,9950
       Intangible Assets 
15,878
28,790
28,119
93,027
110,434
110,43493,02728,11928,79015,878
       Long-term Assets Other 
21,128
24,108
24,622
9,629
1,820
1,8209,62924,62224,10821,128
> Total Liabilities 
39,302
182,872
734,707
524,195
284,500
284,500524,195734,707182,87239,302
   > Total Current Liabilities 
39,302
180,665
714,204
510,753
274,163
274,163510,753714,204180,66539,302
       Short Long Term Debt 
0
2,220
20,061
8,325
16,257
16,2578,32520,0612,2200
       Accounts payable 
16,603
62,004
360,651
171,172
77,609
77,609171,172360,65162,00416,603
       Other Current Liabilities 
8,507
0
598
11,239
160
16011,23959808,507
   > Long-term Liabilities 
0
2,207
20,503
13,443
10,337
10,33713,44320,5032,2070
> Total Stockholder Equity
293,203
972,361
3,273,637
4,166,227
3,827,249
3,827,2494,166,2273,273,637972,361293,203
   Common Stock00000
   Retained Earnings 
135,155
746,157
1,326,208
2,207,421
1,841,175
1,841,1752,207,4211,326,208746,157135,155
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 00000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue754,697
Cost of Revenue-386,541
Gross Profit368,156368,156
 
Operating Income (+$)
Gross Profit368,156
Operating Expense-627,867
Operating Income126,829-259,711
 
Operating Expense (+$)
Research Development121,169
Selling General Administrative92,549
Selling And Marketing Expenses0
Operating Expense627,867213,719
 
Net Interest Income (+$)
Interest Income45,569
Interest Expense-1,459
Other Finance Cost-1,428
Net Interest Income42,682
 
Pretax Income (+$)
Operating Income126,829
Net Interest Income42,682
Other Non-Operating Income Expenses0
Income Before Tax (EBT)197,439126,829
EBIT - interestExpense = -1,459
180,576
182,035
Interest Expense1,459
Earnings Before Interest and Taxes (EBIT)0198,898
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax197,439
Tax Provision-17,158
Net Income From Continuing Ops180,281180,281
Net Income180,576
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-42,682
 

Technical Analysis of Hangzhou Alltest Biotech Co. Ltd. A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hangzhou Alltest Biotech Co. Ltd. A. The general trend of Hangzhou Alltest Biotech Co. Ltd. A is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hangzhou Alltest Biotech Co. Ltd. A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hangzhou Alltest Biotech Co. Ltd. A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 75.98 < 76.98 < 78.27.

The bearish price targets are: 62.02 > 61.50 > 61.26.

Tweet this
Hangzhou Alltest Biotech Co. Ltd. A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hangzhou Alltest Biotech Co. Ltd. A. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hangzhou Alltest Biotech Co. Ltd. A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hangzhou Alltest Biotech Co. Ltd. A. The current macd is 1.06000814.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou Alltest Biotech Co. Ltd. A price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hangzhou Alltest Biotech Co. Ltd. A. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hangzhou Alltest Biotech Co. Ltd. A price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hangzhou Alltest Biotech Co. Ltd. A. The current adx is 24.73.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hangzhou Alltest Biotech Co. Ltd. A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hangzhou Alltest Biotech Co. Ltd. A. The current sar is 67.96.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hangzhou Alltest Biotech Co. Ltd. A. The current rsi is 64.08. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Relative Strength Index (RSI) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hangzhou Alltest Biotech Co. Ltd. A. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou Alltest Biotech Co. Ltd. A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Stochastic Oscillator ChartHangzhou Alltest Biotech Co. Ltd. A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hangzhou Alltest Biotech Co. Ltd. A. The current cci is 102.69.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Commodity Channel Index (CCI) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hangzhou Alltest Biotech Co. Ltd. A. The current cmo is 39.66.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Chande Momentum Oscillator (CMO) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hangzhou Alltest Biotech Co. Ltd. A. The current willr is -28.21917808.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hangzhou Alltest Biotech Co. Ltd. A is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hangzhou Alltest Biotech Co. Ltd. A Daily Williams %R ChartHangzhou Alltest Biotech Co. Ltd. A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hangzhou Alltest Biotech Co. Ltd. A.

Hangzhou Alltest Biotech Co. Ltd. A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hangzhou Alltest Biotech Co. Ltd. A. The current atr is 2.21761808.

Hangzhou Alltest Biotech Co. Ltd. A Daily Average True Range (ATR) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hangzhou Alltest Biotech Co. Ltd. A. The current obv is 18,958,271.

Hangzhou Alltest Biotech Co. Ltd. A Daily On-Balance Volume (OBV) ChartHangzhou Alltest Biotech Co. Ltd. A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hangzhou Alltest Biotech Co. Ltd. A. The current mfi is 63.93.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hangzhou Alltest Biotech Co. Ltd. A Daily Money Flow Index (MFI) ChartHangzhou Alltest Biotech Co. Ltd. A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hangzhou Alltest Biotech Co. Ltd. A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Hangzhou Alltest Biotech Co. Ltd. A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hangzhou Alltest Biotech Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.084
Ma 20Greater thanMa 5065.676
Ma 50Greater thanMa 10066.779
Ma 100Greater thanMa 20064.809
OpenGreater thanClose68.540
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hangzhou Alltest Biotech Co. Ltd. A with someone you think should read this too:
  • Are you bullish or bearish on Hangzhou Alltest Biotech Co. Ltd. A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hangzhou Alltest Biotech Co. Ltd. A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hangzhou Alltest Biotech Co. Ltd. A

I send you an email if I find something interesting about Hangzhou Alltest Biotech Co. Ltd. A.


Comments

How you think about this?

Leave a comment

Stay informed about Hangzhou Alltest Biotech Co. Ltd. A.

Receive notifications about Hangzhou Alltest Biotech Co. Ltd. A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.